iovance biotherapeutics iovance biotherapeutics iovance biotherapeutics, inc. is a biopharmaceutical startup based in san carlos, california. the company works to develop tumor-infiltrating lymphocyte (til) therapies against cancer. iovance biotherapeutics, inc.formerlylion biotechnologies, inc.typepublic companytraded asnasdaq: iovarussell 2000 componentindustrybiotechnologypharmaceuticalcancer immunotherapyfounded2007 (2007)headquarterssan carlos, california, u.s.key peoplesteven rosenbergnumber of employees319 (december 31, 2021)websiteiovance.com history the company was founded in 2007 as genesis biopharma. in 2013, lion merged with genesis biopharma аnd became lion bio pharma, then rebranded to iovance in 2017. drug pipeline iovance has a til treatment undergoing clinical trials against melanoma (investigational id: ln-144, tradename: lifileucel). iovance is investigating a til therapy against cervical and head and neck cancers (investigational id: ln-145).